Methyl 4-bromo-6-cyanobenzo[b]thiophene-2-carboxylate, 98%, 100mg

N-(4-Bromo-phenyl)-malonamic acid ethyl ester, 95.0%, 1g

4-Fluoro-N-methylbenzenesulfonamide, 95.0%, 10g

Bromo-PEG1-C2-Boc, 98.58%, 1g

4-(5-bromo-2-thienyl)-2-methyl-1,3-thiazole, 95.0%, 1g

3,5-Dimethylisoxazole-4-carboxylic Acid>98.0%(HPLC)(T)5g

sodium 5-sulfanylidene-4,5-dihydro-1H-1,2,3-triazol-1-ide, 95%, 25g

(S)-3-Fluoropiperidine hydrochloride, 95+%, 250mg

(R)-tert-Butyl 2-(4-bromophenyl)pyrrolidine-1-carboxylate, 97.0%, 250mg

4-Hydroxypiperidine-1-carboxylic acid isopropyl ester, 95.0%, 100g

Anthron, p.a., ACS, 10 g, kunststoffverpackung.

(2E)-1-(2,4-dichlorophenyl)-3-(4-fluorophenyl)prop-2-en-1-one, 95.0%, 10g

5-Fluoro-2-methylaniline, 99.0%, 100g